A patient trying to heal from an injury still needs a proper diagnosis, appropriate rehabilitation, progressive loading, adequate protein, sleep, hydration, metabolic support, and realistic timelines
But in practice, and especially with regard to synthetic and recombinant peptide forms, there are some considerable potential safety concerns: Immunogenicity Most notably, per a 2020 assessment on therapeutic peptide safety, synthetic and recombinant peptides pose the risk of immunogenicity the ability of a substance to provoke an immune response.15 An immunogenicity-inducing peptide, when introduced to the body, would cause the bodys immune system to perceive the peptide not as a medication but as a threat
Reducing Inflammation Chronic inflammation damages hair follicles
The most notable reduction in fissures with the DSIP-CBBBP fusion peptide group highlights its potential efficacy in improving brain tissue morphology